Phase 1 Open Label Trial of MST-0312 Alone and in Combination in Subjects With Solid Malignancies

Clinical trial NCT07610941 · RECRUITING

Trial details

NCT number: NCT07610941
Sponsor: Mestag Therapeutics Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer-Neoplasms

Start date: 2026-04-09
Primary completion: 2029-12-31
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.